The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Bayer Schering Pharma; Ipsen; Merck Serono; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bayer Schering Pharma; Ipsen; Merck Serono; Roche/Genentech
Research Funding - Merck Serono (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer Schering Pharma; Ipsen; Merck Serono; MSD Oncology; Roche/Genentech
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial.
 
Thierry Conroy
No Relationships to Disclose
 
Pierre-Luc Etienne
No Relationships to Disclose
 
Emmanuel Rio
No Relationships to Disclose
 
Ludovic Evesque
Honoraria - AstraZeneca; SERVIER
 
Nathalie Mesgouez-Nebout
No Relationships to Disclose
 
Veronique Vendrely
No Relationships to Disclose
 
Xavier Artignan
No Relationships to Disclose
 
Olivier Bouche
Consulting or Advisory Role - Amgen; AstraZeneca; MSD Oncology; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Amgen; Bayer; Merck Serono; Pierre Fabre; Sanofi; Servier
 
Alice Boileve
Travel, Accommodations, Expenses - Ipsen; Merck
 
Matthieu Delaye
No Relationships to Disclose
 
Dany Gargot
No Relationships to Disclose
 
Valerie Boige
No Relationships to Disclose
 
Nathalie Bonichon-Lamichhane
No Relationships to Disclose
 
Christophe Louvet
Consulting or Advisory Role - Amgen; Merck; MSD Oncology; Roche
Travel, Accommodations, Expenses - Merck; Roche
 
Christelle De La Fouchardiere
Honoraria - Merck Serono; Merck Serono; Roche; Roche
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Eisai; Incyte; Ipsen; Ipsen; Lilly; MSD Oncology; Pierre Fabre; Roche; SERVIER
Research Funding - Pierre Fabre (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Pierre Fabre; Roche; SERVIER; SERVIER
Other Relationship - Amgen; Incyte; MSD Oncology
 
Clotilde Morand
No Relationships to Disclose
 
Veronica Pezzella
No Relationships to Disclose
 
Eric Rullier
No Relationships to Disclose
 
Florence Castan
No Relationships to Disclose
 
Christophe Borg
Consulting or Advisory Role - Bayer; MSD Oncology; Pierre Fabre; Roche/Genentech
Research Funding - Roche/Genentech (Inst)